AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT (vol 22, pg 231, 2016)

被引：77

作者：

Bailey, Timothy S.

机构：

[1] AMCR Institute Escondido, University of California, San Diego School of Medicine

[2] Grunberger Diabetes Institute, Internal Medicine and Molecular Medicine and Genetics, Wayne State University School of Medicine

[3] Emory University School of Medicine, Atlanta, GA

[4] Metabolic Institute of America, American College of Endocrinology, Tarzana, CA

[5] University of Washington, School of Medicine, Seattle, WA

[6] Sansum Diabetes Research Institute, University of Southern California, Keck School of Medicine, Attending Physician-Santa Barbara County Health Care Services

[7] University of Central, Florida College of Medicine, Orlando, FL

[8] Biomedical Informatics Consultants LLC, Potomac, MD

[9] Yale School of Medicine, New Haven, CT

[10] AMCR Institute, Escondido, CA

来源：

ENDOCRINE PRACTICE | 2016年 / 22卷 / 02期

关键词：

D O I：

10.4158/EP151124.CS

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician. © 2016 American Association of Clinical Endocrinologists.

引用

页码：231 / 261

页数：1